BSYI (Biosyntech) Cyclically Adjusted PS Ratio: (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biosyntech Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biosyntech  (OTCPK:BSYI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Biosyntech Cyclically Adjusted PS Ratio Related Terms


Biosyntech Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Biosyntech's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyntech Cyclically Adjusted PS Ratio Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BSYI vs NSPX, HSTC, PZRXQ: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Biosyntech's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyntech Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosyntech's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Biosyntech's Cyclically Adjusted PS Ratio falls into.



Biosyntech Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Biosyntech's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2009 is calculated as:

For example, Biosyntech's adjusted Revenue per Share data for the three months ended in Dec. 2009 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2009 (Change)*Current CPI (Dec. 2009)
=0/90.7032*90.7032
=0.000

Current CPI (Dec. 2009) = 90.7032.

Biosyntech Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200003 0.000 74.901 0.000
200006 0.002 75.454 0.002
200009 0.001 75.928 0.001
200012 0.000 76.402 0.000
200103 0.001 76.719 0.001
200106 0.000 77.983 0.000
200109 0.001 77.904 0.001
200112 0.004 76.956 0.005
200203 0.001 78.141 0.001
200206 0.001 78.931 0.001
200209 0.001 79.721 0.001
200212 0.001 79.879 0.001
200303 0.002 81.459 0.002
200306 0.002 80.985 0.002
200309 0.000 81.459 0.000
200312 0.002 81.538 0.002
200403 0.001 82.091 0.001
200406 0.000 83.039 0.000
200409 0.001 82.960 0.001
200412 0.003 83.276 0.003
200503 0.000 83.987 0.000
200506 0.000 84.461 0.000
200509 0.000 85.647 0.000
200512 0.001 85.015 0.001
200603 0.000 85.805 0.000
200606 0.000 86.516 0.000
200609 0.000 86.279 0.000
200612 0.001 86.437 0.001
200703 0.001 87.780 0.001
200706 0.000 88.412 0.000
200709 0.001 88.412 0.001
200712 0.000 88.491 0.000
200803 0.002 88.965 0.002
200806 0.000 91.177 0.000
200809 0.000 91.414 0.000
200812 0.000 89.518 0.000
200903 0.000 90.071 0.000
200906 0.000 90.940 0.000
200909 0.001 90.624 0.001
200912 0.000 90.703 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biosyntech Business Description

Address 475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.